Curtis Gerald Jones

Title: Curtis Gerald Jones: Innovator in Hematology

Introduction

Curtis Gerald Jones is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of hematology, particularly in the detection of platelet-activating antibodies. With a total of two patents to his name, Jones has demonstrated a commitment to advancing medical diagnostics.

Latest Patents

Jones's latest patents focus on methods for detecting platelet activation in patients suspected of having heparin-induced thrombocytopenia (HIT). The first patent outlines a method that involves obtaining a blood sample from a patient, incubating platelet factor 4 (PF4) with a sample of platelets, and measuring the extent of platelet activation. An increase in platelet activation compared to normal blood samples indicates the presence of HIT. The second patent presents a similar method, reinforcing the importance of accurate detection in clinical settings.

Career Highlights

Throughout his career, Jones has worked with esteemed organizations such as the BloodCenter Research Foundation and the Versiti Blood Research Institute Foundation, Inc. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Jones has had the opportunity to work alongside notable colleagues, including Richard H. Aster and Daniel W. Bougie. Their combined expertise has furthered advancements in the understanding and treatment of hematological conditions.

Conclusion

Curtis Gerald Jones is a distinguished inventor whose work has significantly impacted the field of hematology. His innovative methods for detecting platelet activation are vital for improving patient outcomes in cases of heparin-induced thrombocytopenia.